183 filings
Page 8 of 10
DEFA14A
7mivyctlyqqenm
26 Apr 19
Additional proxy soliciting materials
7:26am
DEF 14A
3xkgcusfmxw6nj
26 Apr 19
Definitive proxy
7:23am
S-8
7vs39 2f07
25 Mar 19
Registration of securities for employees
4:45pm
S-8
3x4vbiks
25 Mar 19
Registration of securities for employees
4:38pm
10-K
1wvhs50mkuwm5 nzfrj4
25 Mar 19
Annual report
4:31pm
8-K
70i7h4l dsa
25 Mar 19
AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
7:16am
8-K
1joxemd2qr0k5 oqk
6 Feb 19
Other Events
9:11am
8-K
zati f0ajwocvp
22 Jan 19
Other Events
8:00am
8-K/A
so8vqk6u
11 Jan 19
Departure of Directors or Certain Officers
4:23pm
8-K
zbbg0xio
7 Jan 19
AVROBIO, Inc. Appoints Philip J. Vickers to its Board of Directors
4:56pm
8-K
nhvvp ngyu1fsv8df1
21 Dec 18
AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires
4:19pm
8-K
pwoo5rwnp1 2qu7i57
13 Nov 18
AVROBIO, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
8:17am
8-K
9s685b 9eg8
1 Oct 18
AVROBIO Announces Updated Clinical Data forAVR-RD-01 Gene Therapy
12:00am
8-K
3pr 3p57b1iontshyhet
24 Sep 18
Departure of Directors or Certain Officers
5:12pm
10-Q
oe7kbuf9d1eogts
9 Aug 18
Quarterly report
8:09am
8-K
40n8x
9 Aug 18
AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
8:05am
8-K
mqaz4u2p
25 Jun 18
Departure of Directors or Certain Officers
4:00pm
S-8
aas28 uupvz244uckp
21 Jun 18
Registration of securities for employees
4:10pm
424B4
ea7ahmh43iciu1ba
21 Jun 18
Prospectus supplement with pricing info
4:03pm